COMPANY
GenTegra LLC
GenTegra-developed products include sample collection technology for a wide variety of applications including Tissue sample collection for RNAseq, genomics and transcriptomics, DNA for forensic analysis from crime scenes, or whole blood for dried blood spot analysis and storage. GenTegra’s proprietary Active Chemical Protection™, ACP formulation protects, RNA immediately as it elutes the purification column providing a new and more thorough protection. From company website Source · Oct 13, 2026
NIH awards 5
- NIH award 5R44AI132032-05 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SU, NAN; recipient as written: GENTEGRA, LLC, PLEASANTON, CA. Stabilization of the RNA Complement of Enveloped Viruse source ↗
- NIH award 5R44AI132032-04 FY2020: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SU, NAN; recipient as written: GENTEGRA, LLC, PLEASANTON, CA. Stabilization of the RNA Complement of Enveloped Viruse source ↗
- NIH award 2R44AI132032-03 FY2019: $817,026 awarded for that fiscal year; activity R44 (SBIR); PI NASARABADI, SHANAVAZ; recipient as written: GENTEGRA, LLC, PLEASANTON, CA. Stabilization of the RNA Complement of Envel source ↗
- NIH award 5R44AI132032-02 FY2018: $936,558 awarded for that fiscal year; activity R44 (SBIR); PI NASARABADI, SHANAVAZ; recipient as written: GENTEGRA, LLC, PLEASANTON, CA. A New Filter Paper Technology for Flavivirus source ↗
- NIH award 1R44AI132032-01 FY2017: $909,182 awarded for that fiscal year; activity R44 (SBIR); PI NASARABADI, SHANAVAZ; recipient as written: GENTEGRA, LLC, PLEASANTON, CA. A New Filter Paper Technology for Flavivirus source ↗